Brief: Apyx Medical Corporation Reports Fourth Quarter And Full Year 2022 Financial Results Introduces Full Year 2023 Financial Outlook
March 16 (Reuters) - Apyx Medical Corp APYX.O :
* ORATION REPORTS FOURTH QUARTER AND FULL YEAR 2022
FINANCIAL
RESULTS; INTRODUCES FULL YEAR 2023 FINANCIAL OUTLOOK
* Q4 REVENUE FELL 25 PERCENT TO $12.6 MILLION
* NET LOSS ATTRIBUTABLE TO STOCKHOLDERS FOR THREE MONTHS
ENDED
DECEMBER 31, 2022 WAS $6.0 MILLION, OR $0.17 PER SHARE
* EXPECTS TOTAL REVENUE IN RANGE OF $58.0 MILLION TO $61.0
MILLION
FOR FY 2023
Source text for Eikon: ID:nBw544xSSa
Further company coverage: APYX.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Apyx Medical
See all newsBrief: Apyx Medical - Appoints Stavros Vizirgianakis As Executive Chairman Effective June 11, 2026
Brief: Apyx Medical Corporation Receives Expanded FDA 510(K) Clearance Adding Power Liposuction Capability To AYON Body Contouring System™
Apyx Medical Q1 revenue beats estimates, outlook raised
Preview: Weight-loss revolution sparks new appetite for aesthetics firms
Apyx Medical Q4 revenue beats on Surgical Aesthetics unit strength